Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors

Introduction Inflammatory arthritis (IA) conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, are characterised by inflammatory infiltration of the joints. Biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic disease-modifying anti...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Robin Christensen, Lars Erik Kristensen, Daniel Furst, Torkell Ellingsen, Sabrina Mai Nielsen, Simon Tarp, Esben Malm, Johannes Berg, John P. A. Ioannidis, Josef S. Smolen, Peter C. Taylor
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2021-09-01
Serie:	BMJ Open
Accesso online:	https://bmjopen.bmj.com/content/11/9/e049850.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!